S&P 500 Technology Sector SEC Filings — October 16, 2026

FY2026 revenue $74.2B, +6% USD / +5% LC, with Managed Services (+8%) outgrowing Consulting (+5% USD, +3% LC); Consulting revenue share flat at 50% indicates mix shift toward recurring work

EMEA +9% USD and Communications, Media & Technology +11% and Financial Services +9% lead growth, outpacing Americas (+4%) and Health & Public Service (+3%)

Asia Pacific grew 8% in local currency but only 7% in USD, a currency headwind to reported results worth monitoring for FX-driven earnings volatility

CEO Ghazi Sassine exercised 14,604 options at $135.88 and sold the same 14,604 shares at $462.84 (~$6.76M) under a 10b5-1 plan, retaining 76,865 shares; the sale is material and sized relative to a ~$1.98M option exercise, implying a large realized gain

CEO Matthew Murphy sold 7,500 shares at $235.47 (~$1.77M) under a 10b5-1 plan, retaining 778,363 shares, while also taking $885K in tax withholding; pre-planned selling reduces but does not eliminate the conviction signal

President Sandeep Bharathi sold 3,685 shares at $234.97 (~$866K) under a 10b5-1 plan after exercising 6,030 shares, retaining 58,748 shares; combined with the CEO sale, two senior Marvell executives sold within the same filing window at ~$235

Sr. VP Paul Cunningham sold 2,000 shares at $324.13 (~$648K) after exercising 1,000 options at $138.02, retaining 119,612 shares; a modest, plan-driven sale with a large embedded gain on the option exercise

Insider activity is dominated by tax-withholding dispositions at $178.40 (CEO Amon 8,232 shares ~$1.47M; CFO Palkhiwala 3,267 shares ~$583K) alongside RSU/option conversions, with no open-market sales from the CEO or CFO, a neutral-to-mildly-constructive reading

CFO Palkhiwala retains 23,299 shares and CEO Amon retains 188,487 shares after the reported transactions, indicating continued equity alignment despite routine vesting

Director awards to Maynard Webb (67 Class A shares, 3,265 held) and Barbara Messing (64 shares, 10,254 held) are immaterial in size but confirm board equity compensation is being paid in stock rather than cash

Health & Public Service grew only 3% USD and 2% LC, the weakest industry group in the filing, indicating structural softness in a vertical that should be a core growth engine

Consulting grew just 5% USD and 3% LC versus 8% for Managed Services; with consulting still ~50% of revenue, the mix shift leaves top-line growth more exposed to discretionary spending cycles

Americas revenue grew only 4%, the slowest of the major regions outside Health & Public Service, creating a concentration risk given its size in total revenue

Asia Pacific local-currency growth (8%) exceeded USD growth (7%), so currency translation is eroding reported results; sustained dollar strength could pressure reported growth below the 6% headline

CEO sale of ~$6.76M at $462.84 represents the largest disposal in the stream and, though 10b5-1 planned, clusters with the broader EDA/semis selling pattern at elevated valuations

CEO and President sold within the same window (~$2.6M combined in open-market sales at ~$235), with both trades executed under 10b5-1 plans, which can mask discretionary intent and warrants tracking of future plan adoptions

Sr. VP exercised options at $138.02 and sold at $324.13, a ~135% gain on the exercised tranche; the realized gain combined with a plan-based sale is a signal of partial profit-taking rather than a directional view

Multiple executives (CEO, CFO, CTO, CHRO, QTL President) had large withholding dispositions at $178.40, aggregating well over $3M across the group; while routine, the volume concentrates equity-based cost and dilution pressure in a single vesting cycle

Managed Services growing 8% versus Consulting's 5% USD signals a structurally more recurring revenue base; if the trend holds, margin expansion from mix is a plausible alpha thesis for FY2027

EMEA (+9% USD) and Communications, Media & Technology (+11%) are the fastest-growing segments; a rotation toward these verticals in portfolio weighting would capture the strongest demand signal in the filing

Asia Pacific's gap between local-currency (8%) and USD (7%) growth implies a tailwind to reported results if the dollar weakens; the stock's reported growth may be understated relative to underlying demand

With the CEO retaining 188,487 shares and the CFO 23,299 after vesting, and no open-market sales from the top two executives, the Qualcomm group shows less selling pressure than Marvell or Synopsys at comparable price levels

Two senior executives sold at ~$235 under pre-set plans; plan-based sales rarely reflect a change in fundamental view, so the selling may create a near-term technical entry point for investors who view the stock as fundamentally intact

Cunningham's sale is modest (~$648K) and under a 10b5-1 plan, so the disposal is a bounded and known overhang rather than an open-ended one, supporting a neutral-to-constructive view on EDA insider supply

Director compensation paid in Class A stock (Webb 3,265 held, Messing 10,254 held) aligns board incentives with shareholders, a governance positive for a high-growth adtech name

Of the open-market sales in the stream (Marvell CEO, Marvell President, Synopsys CEO, Cadence Sr. VP), all four were executed under 10b5-1 plans, totaling roughly $9.7M, while Qualcomm's disposals were tax-withholding only; the pattern implies sector-wide profit-taking at elevated prices, with planned sales reducing signal value but not eliminating it

Accenture's Managed Services (+8%) outpacing Consulting (+5% USD, +3% LC) across a $74.2B base reveals a clear demand shift toward recurring, outsourced delivery; the implication for peer IT services names is pressure on pure-play consulting multiples and a premium for managed-service exposure

Accenture's Asia Pacific (8% LC vs 7% USD) and the broader 6% USD vs 5% LC headline gap show FX is a modest tailwind globally but a headwind in APAC; investors should adjust regional growth expectations for currency when comparing services peers

Across Qualcomm, Marvell and AppLovin, the majority of Form 4 activity is RSU/option vesting and tax withholding rather than open-market trading; net insider selling in the stream is therefore best read as compensation-driven dilution management rather than directional conviction

Director awards at AppLovin and routine RSU settlements across Qualcomm signal consistent use of stock-based pay to align management and board with shareholders, supporting governance quality across the large-cap tech cohort

Watch whether Health & Public Service growth recovers from 3% and whether Managed Services sustains an 8% pace versus Consulting's 5%; next quarterly report will confirm the mix trend (date to be confirmed from the filing's calendar)

Track whether the 1-point USD versus local-currency gap in Asia Pacific widens, as it would indicate persistent currency erosion of reported growth

Monitor further Form 4 filings for additional planned sales following the $6.76M disposal at $462.84; a second tranche would strengthen the bearish read

Watch for new or amended 10b5-1 plans from CEO Murphy and President Bharathi, since plan changes in a short window would be a sharper signal than the existing pre-planned sales

Track whether CEO Amon and CFO Palkhiwala add open-market purchases or continue holding; absence of buying after a large vesting cycle is a neutral signal, while any open-market sale would be a material change

Monitor whether Sr. VP Cunningham's pattern of option exercise plus 10b5-1 sale repeats, which would indicate a systematic sell program rather than a one-off

Watch the next proxy and Form 4 cycle for changes in director equity grants, as a shift toward cash or larger awards would be a governance datapoint